cemiplimab Cancer Therapies | Cancer Search

{name}

{subtitle}

cemiplimab

biomarker

PD-L1 Expression (TPS >= 50%)

condition

Non-Small Cell Lung Carcinoma

disease state

Locally advanced, +1 more state

therapeutic contexts

First line

drug

cemiplimab

drug type

immunotherapy

cemiplimab

biomarker

PD-L1 Expression (TPS >= 50%)

condition

Non-Small Cell Lung Carcinoma

disease state

Advanced, +1 more state

therapeutic contexts

First line

drug

cemiplimab

drug type

immunotherapy

cemiplimab

condition

Basal Cell Carcinoma

disease state

Locally advanced, +1 more state

drug

cemiplimab

drug type

immunotherapy

cemiplimab

condition

Skin Squamous Cell Carcinoma

disease state

Locally advanced, +1 more state

drug

cemiplimab

drug type

immunotherapy

cemiplimab

condition

Cervical Carcinoma

disease state

Metastatic, +1 more state

therapeutic contexts

Subsequent line

drug

cemiplimab

drug type

immunotherapy

5 Items
Page 1 of 1